Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flarin in COVID-19 Acute Hypoxemic Respiratory Failure
NCT04334629Phase 4Withdrawn
- Sponsor
- King's College London
- Start
- May 2020
- Primary completion
- May 2021
- Countries
- 1
01
Overview
A Phase 4 trial of ibuprofen in coronavirus disease 2019 (COVID-19), acute hypoxemic respiratory failure (AHRF), sponsored by King's College London. Planned start May 2020; status: withdrawn.
02
Drugs
ibuprofen
03
Conditions
coronavirus disease 2019 (COVID-19)acute hypoxemic respiratory failure (AHRF)
Beyond the preview
Go deeper on NCT04334629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04334629.